Advancements in Computer-Aided Drug Design for Pharmaceutical Research

By: Hridkamal Roy, Editor

Computer aided drug design (CADD) has played a pivotal role in the sector of pharmaceutical development. An array of techniques and innovations have come into the picture that are being able to provide acceleration and stimulation

The Future of Kidney Transplants in India

By: Hridkamal Roy, Editor

A milestone has been achieved by Fortis Hospital, Bengaluru with two successful cases of kidney transplant by means of robotic surgery.

Why India is Gaining Popularity for Clinical Trials

By: Hridkamal Roy, Editor

India has successfully performed the first human clinical trial of gene therapy for ‘haemophilia A’ at the Christian Medical College – Vellore as was informed by Union Science and Technology Minister Jitendra Singh on Wednesday

Usage of Conversational AI in the Health Insurance Sector

By: Hridkamal Roy, Editor

At the Conversational AI and Customer Experience summit last week, PB Fintech President, Rajiv Gupta stated how AI systems are being put into use to drive progress in the health insurance sector of the country

Supply Chain Deficiencies CDSCO can solve with the new GDP Guidelines

By: Hridkamal Roy, Editor, India Pharma Outlook

The Central Drugs Standard Control Organization (CDSCO) has recently released a document on Good Distribution Practices (GDP) that concerns all pharmaceutical products being sold in India.

Impact of Rise in Essential Drug Prices in India

By: Hridkamal Roy, Editor, India Pharma Outlook

Pharmaceutical manufacturers are now permitted to adjust the Maximum Retail Price (MRP) of scheduled drug formulations in line with the recent Wholesale Price Index (WPI) change of 0.00551% independently without government’s approval.

Inefficiencies Hindering Generics Growth in India

By: Hridkamal Roy, Editor, India Pharma Outlook

Physicians have blamed lack of standardization as the cause for not prescribing generics to patients. Sources from the medical community informed India Pharma Outlook that the quality and efficacy of generic medicines are the primary reasons why

Ways in Which UCPMP can Curb Unethical Pharma Marketing Practices

By: Hridkamal Roy, Editor, India Pharma Outlook

Research conducted by India Pharma Outlook revealed that many physicians have been bribed for decades to prescribe specific medicines and, in an extended number of cases oncologists have been bribed to validate clinical trials of certain drugs.

© 2024 India Pharma Outlook. All Rights Reserved.